Princeton Biopharma Capital Partners
North America, New York, United States, New York
Description
A private equity investment firm
Investor Profile
Princeton Biopharma Capital Partners has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Debt Financing rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Consumer Electronics.
Stage Focus
- Series A (20%)
- Seed (20%)
- Debt Financing (20%)
- Private Equity (20%)
- Series Unknown (20%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Consumer Electronics
- Biotechnology
- Pharmaceutical
- Veterinary
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
